Viewing Study NCT02840994


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-27 @ 8:27 AM
Study NCT ID: NCT02840994
Status: COMPLETED
Last Update Posted: 2020-02-27
First Post: 2016-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
Sponsor: Bavarian Nordic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CV301, NSCLC, Pembrolizumab, Nivolumab View